ICON plc to Present at the Jefferies London Healthcare Conference
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc will present at the Jefferies London Healthcare Conference on Thursday,
CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference
About CRISPR Therapeutics Since its inception over a decade ago, CRISPR Therapeutics has transformed from a research-stage company advancing programs in the field of gene editing, to a company that recently celebrated the historic approval of the first-ever CRISPR-based therapy and has a diverse portfolio of product candidates across a broad range of disease areas including hemoglobinopathies,
Masimo to Present in the Jefferies London Healthcare Conference
Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be available on the Masimo website at A replay of the webcast will be available following the live presentation.
DUBLIN-- ( BUSINESS WIRE )-- ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the third quarter ended ...
Analysts are optimistic, shown by an upward trend in estimates, reflecting a growing confidence in ICON’s performance trajectory. ICON PLC’s stock recently closed at $212.18, with Stock Target Advisor ...
In a report released yesterday, Etzer Darout from BMO Capital reiterated a Buy rating on Acrivon Therapeutics, Inc. (ACRV – Research ...
Born on a farm in Newton, Iowa in 1942, Dr. Kerfoot attended the University of Iowa College of Nursing to receive her Bachelor’s and Master’s degrees. Her PhD in Nursing was granted by the University ...
Jazmin Evans was diagnosed with kidney disease at the age of 17 in 2012. She received a kidney transplant in July 2023, after ...
Ami Fadia, an analyst from Needham, maintained the Buy rating on Immuneering (IMRX – Research Report ... A significant focus for investors is the ongoing Phase 2a clinical study of Immuneering’s ...
The National Institute of Aging awarded a $7.3 million research grant for the study of NU-9 as a treatment for ...
At this year’s Fall convocation ceremonies on Nov. 20 and 21, the university will honour the achievements of artist, poet and ...
"The entertainment value will be epic," the billionaire said.
The funding will make the hospital's new MRI truly state-of-the-art by adding new imaging methods, allowing users to see more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback